Cellular and molecular biology of Candida albicans estrogen response

被引:75
作者
Cheng, G [1 ]
Yeater, KM [1 ]
Hoyer, LL [1 ]
机构
[1] Univ Illinois, Dept Pathobiol, Urbana, IL 61802 USA
关键词
D O I
10.1128/EC.5.1.180-191.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Candida albicans is the most common etiological agent of vaginal candidiasis. Elevated host estrogen levels and the incidence of vaginal candidiasis are positively associated. Elevated estrogen levels may affect host and/or fungal cells. This study investigates the effect of 17-beta-estradiol, 17-alpha-estradiol, ethynyl estradiol, and estriol on several C albicans strains at concentrations ranging from 10(-5) to 10(-10) M. The addition of 17-beta-estradiol or ethynyl estradiol to C. albicans cells caused an increase in the number of cells forming germ tubes and an increase in germ tube length in a dose- and strain-dependent manner. The addition of 17-alpha-estradiol or estriol did not have a significant effect on germ tube formation by the cultured cells. Exposure to exogenous estrogens did not significantly change the biomass of any C albicans culture tested. The transcriptional profile of estrogen-treated C albicans cells showed increased expression of CDRI and CDR2 across several strain-estrogen concentration-time point combinations, suggesting that these genes are the most responsive to estrogen exposure. Analysis of strain DSY654, which lacks the CDR1 and CDR2 coding sequences, showed a significantly decreased number of germ tube-forming cells in the presence of 17-beta-estradiol. PDR16 was the most highly up-regulated gene in strain DSY654 under these growth conditions. The cell biology and gene expression data from this study led to a model that proposes how components of the phospholipid and sterol metabolic pathways may interact to affect C albicans germ tube formation and length.
引用
收藏
页码:180 / 191
页数:12
相关论文
共 54 条
[11]  
COLLART MA, 1993, CURRENT PROTOCOLS MO, V2
[12]   NPS@:: Network Protein Sequence Analysis [J].
Combet, C ;
Blanchet, C ;
Geourjon, C ;
Deléage, G .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (03) :147-150
[13]   TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of candida albicans ABC transporters CDR1 and CDR2 [J].
Coste, AT ;
Karababa, M ;
Ischer, F ;
Bille, J ;
Sanglard, D .
EUKARYOTIC CELL, 2004, 3 (06) :1639-1652
[14]   Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy [J].
Cotch, MF ;
Hillier, SL ;
Gibbs, RS ;
Eschenbach, DA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 178 (02) :374-380
[15]   Constitutive activation of the PDR16 promoter in a Candida albicans azole-resistant clinical isolate overexpressing CDR1 and CDR2 [J].
De Deken, X ;
Raymond, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (07) :2700-2703
[16]   A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance [J].
de Micheli, M ;
Bille, J ;
Schueller, C ;
Sanglard, D .
MOLECULAR MICROBIOLOGY, 2002, 43 (05) :1197-1214
[17]   Candida albicans PLD1 activity is required for full virulence [J].
Dolan, JW ;
Bell, AC ;
Hube, B ;
Schaller, M ;
Warner, TF ;
Balish, E .
MEDICAL MYCOLOGY, 2004, 42 (05) :439-447
[18]   Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases SAP4 to SAP6 are required for the invasion of parenchymal organs [J].
Felk, A ;
Kretschmar, M ;
Albrecht, A ;
Schaller, M ;
Beinhauer, S ;
Nichterlein, T ;
Sanglard, D ;
Korting, HC ;
Schäfer, W ;
Hube, B .
INFECTION AND IMMUNITY, 2002, 70 (07) :3689-3700
[19]   Risk factors for vulvovaginal candidiasis: A case-control study among university students [J].
Geiger, AM ;
Foxman, B .
EPIDEMIOLOGY, 1996, 7 (02) :182-187
[20]   ISOLATION OF THE CANDIDA-ALBICANS GENE FOR OROTIDINE-5'-PHOSPHATE DECARBOXYLASE BY COMPLEMENTATION OF S-CEREVISIAE URA3 AND ESCHERICHIA-COLI PYRF MUTATIONS [J].
GILLUM, AM ;
TSAY, EYH ;
KIRSCH, DR .
MOLECULAR & GENERAL GENETICS, 1984, 198 (01) :179-182